Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Cancer Research|November 3, 2007
p53 determines multidrug sensitivity of childhood neuroblastomaChengyuan Xue, Michelle Haber, Claudia Flemming, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and betaR M Turnbull, E L Meczes, M Perenna Rogers, et al.
Oncogene|June 2, 2009
Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptaseJ Yuan, B M-P Yang, Z-H Zhong, et al.
Leukemia|May 21, 2004
Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burdenL J Bendall, S K Nilsson, N I Khan, et al.
Molecular Pharmacology|December 30, 2009
The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugsLaura M High, Barbara Szymanska, Urszula Wilczynska-Kalak, et al.
BMC Genomics|April 22, 2010
Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemiaAmy L Samuels, Violet K Peeva, Rachael A Papa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALLLuke Jones, Jennifer Richmond, Kathryn Evans, et al.
The Journal of Biological Chemistry|March 2, 2013
Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stressChin-Yi Kan, Carlotta Petti, Lauryn Bracken, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2007
A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenograftsVivienna Ong, Natalia L M Liem, Michael A Schmid, et al.
Blood|October 23, 2014
Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cellsDuohui Jing, Vivek A Bhadri, Dominik Beck, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Cancer Research|November 3, 2007
p53 determines multidrug sensitivity of childhood neuroblastomaChengyuan Xue, Michelle Haber, Claudia Flemming, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and betaR M Turnbull, E L Meczes, M Perenna Rogers, et al.
Oncogene|June 2, 2009
Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptaseJ Yuan, B M-P Yang, Z-H Zhong, et al.
Leukemia|May 21, 2004
Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burdenL J Bendall, S K Nilsson, N I Khan, et al.
Molecular Pharmacology|December 30, 2009
The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugsLaura M High, Barbara Szymanska, Urszula Wilczynska-Kalak, et al.
BMC Genomics|April 22, 2010
Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemiaAmy L Samuels, Violet K Peeva, Rachael A Papa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALLLuke Jones, Jennifer Richmond, Kathryn Evans, et al.
The Journal of Biological Chemistry|March 2, 2013
Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stressChin-Yi Kan, Carlotta Petti, Lauryn Bracken, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2007
A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenograftsVivienna Ong, Natalia L M Liem, Michael A Schmid, et al.
Blood|October 23, 2014
Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cellsDuohui Jing, Vivek A Bhadri, Dominik Beck, et al.
Pageof 22